Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preemptive dexmedetomidine dosing to blunt tourniquet-induced blood pressure and heart rate changes in upper extremity orthopedic surgery
IRCT20090129001615N7Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of dexmedetomidine in Perioperative cardiovascular instability (PCVI) (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Change in blood pressure after tourniquet application and Change in heart rate after tourniquet application. Started May 2023; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Perioperative cardiovascular instability (PCVI)
Beyond the preview
Go deeper on IRCT20090129001615N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090129001615N7.